Stephen P. Hack
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 18
- Colorectal Cancer Treatments and Studies 8
- Pancreatic and Hepatic Oncology Research 4
-
- Melanoma and MAPK Pathways 6
- Co-authors
- MacDonald J. Christie (6 shared papers)L. Thomas (5 shared papers)Lev Demidov (5 shared papers)Mario Mandalà (5 shared papers)Luis de la Cruz‐Merino (5 shared papers)Brigitte Dréno (5 shared papers)Ilsung Chang (4 shared papers)Paolo A. Ascierto (5 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Annals of Oncology (4 papers)Journal of Neuroscience (2 papers)Journal of Neurophysiology (2 papers)Expert Opinion on Investigational Drugs (1 paper)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Stephen P. Hack
41 papers receiving 3.2k citations
Stephen P. Hack's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 1.4k
- Hepatology 354
- Molecular Biology 1.6k
- Cellular and Molecular Neuroscience 404
- Pathology and Forensic Medicine 265
Countries citing papers authored by Stephen P. Hack
This map shows the geographic impact of Stephen P. Hack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen P. Hack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen P. Hack more than expected).
Fields of papers citing papers by Stephen P. Hack
This network shows the impact of papers produced by Stephen P. Hack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen P. Hack. The network helps show where Stephen P. Hack may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen P. Hack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma Hit paper breakdown → | 2014 | 1547 |
| 2 | 2016 | 218 | |
| 3 | 2020 | 194 | |
| 4 | 2020 | 154 | |
| 5 | 2015 | 89 | |
| 6 | 1999 | 79 | |
| 7 | 2003 | 77 | |
| 8 | 2005 | 71 | |
| 9 | 2005 | 65 | |
| 10 | 2019 | 62 | |
| 11 | 2004 | 61 | |
| 12 | 1993 | 58 | |
| 13 | 2004 | 58 | |
| 14 | 2014 | 57 | |
| 15 | 2017 | 49 | |
| 16 | 2024 | 47 | |
| 17 | 2003 | 42 | |
| 18 | 2015 | 39 | |
| 19 | 2021 | 36 | |
| 20 | 1986 | 34 |
About Stephen P. Hack
Stephen P. Hack is a scholar working on Oncology, Molecular Biology, Hepatology, Surgery and Cellular and Molecular Neuroscience, having authored 42 papers that have together received 3.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Neuroscience and Neuropharmacology Research (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Melanoma and MAPK Pathways (6 papers), Liver physiology and pathology (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Neuropeptides and Animal Physiology (4 papers). The work is most often cited by research in Oncology (1.4k citations), Hepatology (354 citations), Molecular Biology (1.6k citations), Cellular and Molecular Neuroscience (404 citations) and Pathology and Forensic Medicine (265 citations). Stephen P. Hack has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include MacDonald J. Christie, L. Thomas, Lev Demidov, Mario Mandalà, Luis de la Cruz‐Merino, Brigitte Dréno, Ilsung Chang, Paolo A. Ascierto, Michele Maio and Antoni Ribas. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Neuroscience, Journal of Neurophysiology and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.